[Effects of cotrimoxazole on some macrophage functions: microbicide, tumoricide, production of free oxygen radicals, prostaglandins and leukotrienes].
In order to demonstrate an immunomodulating effect of cotrimoxazole, we investigated its influence on some macrophage (M phi) functions in culture: P815 tumor cells killing, Toxoplasma gondii killing, production of free oxygen radicals by luminol-dependent chemiluminescence, prostaglandins and leukotrienes secretion evaluated after incorporation of tritiated arachidonic acid. In vitro, cotrimoxazole inhibited in a dose-dependent fashion the chemiluminescence of murine resident peritoneal or guinea pig alveolar M phi. Production of prostaglandin (PG) 6-keto-F1 alpha, PGF2 alpha, and 5-hydroxyeicosatetraenoic acid by resident peritoneal M phi was also inhibited. However, PGD2 synthesis by alveolar M phi was enhanced. A second study was performed on peritoneal M phi, resident or elicited in vivo by one intra-peritoneal injection of an extract from Mycobacterium Tuberculosis membranes and obtained from mice pretreated or not by cotrimoxazole per os. Resident M phi from cotrimoxale-treated animals showed increased production of leucotriene B4 compared to M phi from controls. 6-keto-PGF1 alpha and free oxygen radicals production by elicited M phi was greatly enhanced by cotrimoxazole whereas thromboxane B2 was reduced. Finally cotrimoxazole enhanced intracellular killing of Toxoplasma gondii and cytotoxicity for tumor cells P815 by resident but not by elicited M phi. It is concluded that cotrimoxazole can modulate MO activation and some M phi functions involved in immune homeostasis. This data could help to understand why an antibiotic such as cotrimoxazole, which is known to be frequently used in immunocompromised hosts, is also efficient in Wegener's granulomatosis.
Carré
P
P
Service de Pneumologie et Allergologie, Hôpital de Rangueil, Toulouse, France.
Forgue
M F
MF
Pipy
B
B
Beraud
M
M
Bessières
M H
MH
Didier
A
A
Leophonte
P
P
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D005609:Free Radicals; D006168:Guinea Pigs; D066298:In Vitro Techniques; D015289:Leukotrienes / Q000096:biosynthesis*; D008262:Macrophage Activation / Q000187:drug effects* / Q000502:physiology; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D010100:Oxygen / Q000032:analysis*; D011453:Prostaglandins / Q000096:biosynthesis*; D013420:Sulfamethoxazole / Q000494:pharmacology*; D014122:Toxoplasma / Q000187:drug effects*; D014295:Trimethoprim / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005609:Free Radicals; D015289:Leukotrienes; D011453:Prostaglandins; D014295:Trimethoprim; D013420:Sulfamethoxazole; D010100:Oxygen
Effets du cotrimoxazole sur certaines fonctions de macrophages: microbicidie, tumoricidie, production de radicaux libres oxygénés, de prostaglandines et de leucotriènes.